A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

Terminated

Phase 2/3 Results N/A

Trial Description

The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.

Conditions

Interventions

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Patient Involvement

Patients will be ranomized to receive either ONO-2506 (4 mg/kg/hr or 10 mg/kg/hr) in 5 consecutive daily 1hour infusion doses or placebo.

Outcomes

Type Measure Time Frame Safety Issue
Primary Modified Rankin Scale score at 90 days after stroke onset.
Primary Modified Rankin Scale

Sponsors